Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 77

1.

Autologous Hematological Stem Cell Transplantation for Systemic Sclerosis in Israel.

Rimar D, Butbul Aviel Y, Gefen A, Nevo N, Shen-Orr SS, Starosvetsky E, Rosner I, Rozenbaum M, Kaly L, Boulman N, Slobodin G, Zuckerman T.

Isr Med Assoc J. 2020 Feb;22(2):104-110.

2.

PAR1 Expression Predicts Clinical G-CSF CD34+ HSPC Mobilization and Repopulation Potential in Transplanted Patients.

Nevo N, Zuckerman T, Gur-Cohen S, Kollet O, Avemaria F, Shpall EJ, Mendt MC, Nagler A, Brenner B, Ben Arush M, Lapidot T.

Hemasphere. 2019 Aug 20;3(5):e288. doi: 10.1097/HS9.0000000000000288. eCollection 2019 Oct. No abstract available.

3.

Valproic Acid Decreases Endothelial Colony Forming Cells Differentiation and Induces Endothelial-to-Mesenchymal Transition-like Process.

Nevo N, Lecourt S, Bièche I, Kucia M, Cras A, Blandinieres A, Vacher S, Gendron N, Guerin CL, Ratajczak MZ, Smadja DM.

Stem Cell Rev Rep. 2020 Jan 2. doi: 10.1007/s12015-019-09950-y. [Epub ahead of print]

PMID:
31898801
4.

Children and Adults with Refractory Acute Graft-versus-Host Disease Respond to Treatment with the Mesenchymal Stromal Cell Preparation "MSC-FFM"-Outcome Report of 92 Patients.

Bonig H, Kuçi Z, Kuçi S, Bakhtiar S, Basu O, Bug G, Dennis M, Greil J, Barta A, Kállay KM, Lang P, Lucchini G, Pol R, Schulz A, Sykora KW, Teichert von Luettichau I, Herter-Sprie G, Ashab Uddin M, Jenkin P, Alsultan A, Buechner J, Stein J, Kelemen A, Jarisch A, Soerensen J, Salzmann-Manrique E, Hutter M, Schäfer R, Seifried E, Paneesha S, Novitzky-Basso I, Gefen A, Nevo N, Beutel G, Schlegel PG, Klingebiel T, Bader P.

Cells. 2019 Dec 5;8(12). pii: E1577. doi: 10.3390/cells8121577.

5.

Sleeve Gastrectomy in the Elderly.

Nevo N, Eldar SM, Lessing Y, Sabo E, Nachmany I, Hazzan D.

Obes Facts. 2019;12(5):502-508. doi: 10.1159/000502697. Epub 2019 Oct 14.

6.

Protection of Cystinotic Mice by Kidney-Specific Megalin Ablation Supports an Endocytosis-Based Mechanism for Nephropathic Cystinosis Progression.

Janssens V, Gaide Chevronnay HP, Marie S, Vincent MF, Van Der Smissen P, Nevo N, Vainio S, Nielsen R, Christensen EI, Jouret F, Antignac C, Pierreux CE, Courtoy PJ.

J Am Soc Nephrol. 2019 Nov;30(11):2177-2190. doi: 10.1681/ASN.2019040371. Epub 2019 Sep 23.

PMID:
31548351
7.

Heparanase Level in the Microcirculation as a Possible Modulator of the Metastatic Process.

Nevo N, Ghanem S, Crispel Y, Tatour M, Cohen H, Kogan I, Ben-Arush M, Nadir Y.

Am J Pathol. 2019 Aug;189(8):1654-1663. doi: 10.1016/j.ajpath.2019.04.019. Epub 2019 May 23.

PMID:
31128083
8.

Interaction between galectin-3 and cystinosin uncovers a pathogenic role of inflammation in kidney involvement of cystinosis.

Lobry T, Miller R, Nevo N, Rocca CJ, Zhang J, Catz SD, Moore F, Thomas L, Pouly D, Bailleux A, Guerrera IC, Gubler MC, Cheung WW, Mak RH, Montier T, Antignac C, Cherqui S.

Kidney Int. 2019 Aug;96(2):350-362. doi: 10.1016/j.kint.2019.01.029. Epub 2019 Mar 6.

PMID:
30928021
9.

Intrinsic Bone Defects in Cystinotic Mice.

Battafarano G, Rossi M, Rega LR, Di Giovamberardino G, Pastore A, D'Agostini M, Porzio O, Nevo N, Emma F, Taranta A, Del Fattore A.

Am J Pathol. 2019 May;189(5):1053-1064. doi: 10.1016/j.ajpath.2019.01.015. Epub 2019 Feb 19.

PMID:
30794806
10.

Early reoperation following pancreaticoduodenectomy: impact on morbidity, mortality, and long-term survival.

Lessing Y, Pencovich N, Nevo N, Lubezky N, Goykhman Y, Nakache R, Lahat G, Klausner JM, Nachmany I.

World J Surg Oncol. 2019 Jan 31;17(1):26. doi: 10.1186/s12957-019-1569-9.

11.

Interleukin-8 release by endothelial colony-forming cells isolated from idiopathic pulmonary fibrosis patients might contribute to their pathogenicity.

Blandinières A, Gendron N, Bacha N, Bièche I, Chocron R, Nunes H, Nevo N, Rossi E, Crestani B, Lecourt S, Chevret S, Lokajczyk A, Mignon V, Kisaoglu A, Juvin K, Bertil S, Valeyre D, Cras A, Gaussem P, Israël-Biet D, Smadja DM.

Angiogenesis. 2019 May;22(2):325-339. doi: 10.1007/s10456-018-09659-5. Epub 2019 Jan 3.

PMID:
30607696
12.

Gastric Bypass as a Third Bariatric Procedure-Our Experience with 42 Cases.

Nevo N, Abu-Abeid S, Hazzan D, Lahat G, Nachmani I, Eldar SM.

Obes Surg. 2019 Jan;29(1):215-220. doi: 10.1007/s11695-018-3503-6.

PMID:
30294768
13.

SILAC identifies LAD1 as a filamin-binding regulator of actin dynamics in response to EGF and a marker of aggressive breast tumors.

Roth L, Srivastava S, Lindzen M, Sas-Chen A, Sheffer M, Lauriola M, Enuka Y, Noronha A, Mancini M, Lavi S, Tarcic G, Pines G, Nevo N, Heyman O, Ziv T, Rueda OM, Gnocchi D, Pikarsky E, Admon A, Caldas C, Yarden Y.

Sci Signal. 2018 Jan 30;11(515). pii: eaan0949. doi: 10.1126/scisignal.aan0949.

PMID:
29382783
14.

Impaired autophagy bridges lysosomal storage disease and epithelial dysfunction in the kidney.

Festa BP, Chen Z, Berquez M, Debaix H, Tokonami N, Prange JA, Hoek GV, Alessio C, Raimondi A, Nevo N, Giles RH, Devuyst O, Luciani A.

Nat Commun. 2018 Jan 11;9(1):161. doi: 10.1038/s41467-017-02536-7.

15.

Vasorin: a newly identified regulator of ovarian folliculogenesis.

Rimon-Dahari N, Heinemann-Yerushalmi L, Hadas R, Kalich-Philosoph L, Ketter D, Nevo N, Galiani D, Dekel N.

FASEB J. 2018 Apr;32(4):2124-2136. doi: 10.1096/fj.201700057RRR. Epub 2018 Jan 5.

PMID:
29259033
16.

Human sex hormone-binding globulin does not provide metabolic protection against diet-induced obesity and dysglycemia in mice.

Sofer Y, Nevo N, Vechoropoulos M, Shefer G, Osher E, Landis N, Tordjman K, Hammond GL, Stern N.

Endocr Connect. 2018 Jan;7(1):91-96. doi: 10.1530/EC-17-0240. Epub 2017 Nov 15.

17.

Endothelial Microparticles are Associated to Pathogenesis of Idiopathic Pulmonary Fibrosis.

Bacha NC, Blandinieres A, Rossi E, Gendron N, Nevo N, Lecourt S, Guerin CL, Renard JM, Gaussem P, Angles-Cano E, Boulanger CM, Israel-Biet D, Smadja DM.

Stem Cell Rev Rep. 2018 Apr;14(2):223-235. doi: 10.1007/s12015-017-9778-5.

PMID:
29101610
18.

Egfl7 Represses the Vasculogenic Potential of Human Endothelial Progenitor Cells.

d'Audigier C, Susen S, Blandinieres A, Mattot V, Saubamea B, Rossi E, Nevo N, Lecourt S, Guerin CL, Dizier B, Gendron N, Caetano B, Gaussem P, Soncin F, Smadja DM.

Stem Cell Rev Rep. 2018 Feb;14(1):82-91. doi: 10.1007/s12015-017-9775-8.

PMID:
28980146
19.

Converting a Sleeve Gastrectomy to a Gastric Bypass for Weight Loss Failure-Is It Worth It?

Nevo N, Abu-Abeid S, Lahat G, Klausner J, Eldar SM.

Obes Surg. 2018 Feb;28(2):364-368. doi: 10.1007/s11695-017-2856-6.

PMID:
28891022
20.

Regulation of GVBD in mouse oocytes by miR-125a-3p and Fyn kinase through modulation of actin filaments.

Grossman H, Har-Paz E, Gindi N, Levi M, Miller I, Nevo N, Galiani D, Dekel N, Shalgi R.

Sci Rep. 2017 May 22;7(1):2238. doi: 10.1038/s41598-017-02071-x.

21.

Impact of Cystinosin Glycosylation on Protein Stability by Differential Dynamic Stable Isotope Labeling by Amino Acids in Cell Culture (SILAC).

Nevo N, Thomas L, Chhuon C, Andrzejewska Z, Lipecka J, Guillonneau F, Bailleux A, Edelman A, Antignac C, Guerrera IC.

Mol Cell Proteomics. 2017 Mar;16(3):457-468. doi: 10.1074/mcp.M116.063867. Epub 2017 Jan 12.

22.

Environmental and genetic effects on tomato seed metabolic balance and its association with germination vigor.

Rosental L, Perelman A, Nevo N, Toubiana D, Samani T, Batushansky A, Sikron N, Saranga Y, Fait A.

BMC Genomics. 2016 Dec 19;17(1):1047.

23.

Peptides inhibiting heparanase procoagulant activity significantly reduce tumour growth and vascularisation in a mouse model.

Crispel Y, Axelman E, Tatour M, Kogan I, Nevo N, Brenner B, Nadir Y.

Thromb Haemost. 2016 Sep 27;116(4):669-78. doi: 10.1160/TH16-02-0119. Epub 2016 Aug 18.

PMID:
27535490
24.

LIMT is a novel metastasis inhibiting lncRNA suppressed by EGF and downregulated in aggressive breast cancer.

Sas-Chen A, Aure MR, Leibovich L, Carvalho S, Enuka Y, Körner C, Polycarpou-Schwarz M, Lavi S, Nevo N, Kuznetsov Y, Yuan J, Azuaje F; Oslo Breast Cancer Research Consortium (OSBREAC)SauerTorillGeislerJürgenHofvindSolveigBathenTone FBorgenElinEngebråtenOlavFodstadØysteinGarredØysteinGeitvikGry AarumKåresenRolfNaumeBjørnMælandsmoGunhild MariRussnesHege GSchlichtingEllenSørlieThereseLingjærdeOle ChristianSahlbergKristine KleiviSkjervenHelle KristineFritzmanBritt, Ulitsky I, Diederichs S, Wiemann S, Yakhini Z, Kristensen VN, Børresen-Dale AL, Yarden Y.

EMBO Mol Med. 2016 Sep 1;8(9):1052-64. doi: 10.15252/emmm.201606198. Print 2016 Sep.

25.

Angiotensin 1-7 Is a Negative Modulator of Aldosterone Secretion In Vitro and In Vivo.

Shefer G, Marcus Y, Knoll E, Dolkart O, Foichtwanger S, Nevo N, Limor R, Stern N.

Hypertension. 2016 Aug;68(2):378-84. doi: 10.1161/HYPERTENSIONAHA.116.07088. Epub 2016 May 31.

PMID:
27245181
26.

Cystinosin is a Component of the Vacuolar H+-ATPase-Ragulator-Rag Complex Controlling Mammalian Target of Rapamycin Complex 1 Signaling.

Andrzejewska Z, Nevo N, Thomas L, Chhuon C, Bailleux A, Chauvet V, Courtoy PJ, Chol M, Guerrera IC, Antignac C.

J Am Soc Nephrol. 2016 Jun;27(6):1678-88. doi: 10.1681/ASN.2014090937. Epub 2015 Oct 8.

27.

Appropriate expression of Ube2C and Ube2S controls the progression of the first meiotic division.

Ben-Eliezer I, Pomerantz Y, Galiani D, Nevo N, Dekel N.

FASEB J. 2015 Nov;29(11):4670-81. doi: 10.1096/fj.15-274522. Epub 2015 Jul 23.

PMID:
26207029
28.

A mouse model suggests two mechanisms for thyroid alterations in infantile cystinosis: decreased thyroglobulin synthesis due to endoplasmic reticulum stress/unfolded protein response and impaired lysosomal processing.

Gaide Chevronnay HP, Janssens V, Van Der Smissen P, Liao XH, Abid Y, Nevo N, Antignac C, Refetoff S, Cherqui S, Pierreux CE, Courtoy PJ.

Endocrinology. 2015 Jun;156(6):2349-64. doi: 10.1210/en.2014-1672. Epub 2015 Mar 26.

29.

Lysosomal Targeting of Cystinosin Requires AP-3.

Andrzejewska Z, Névo N, Thomas L, Bailleux A, Chauvet V, Benmerah A, Antignac C.

Traffic. 2015 Jul;16(7):712-26. doi: 10.1111/tra.12277. Epub 2015 Mar 24.

30.

The swan-neck lesion: proximal tubular adaptation to oxidative stress in nephropathic cystinosis.

Galarreta CI, Forbes MS, Thornhill BA, Antignac C, Gubler MC, Nevo N, Murphy MP, Chevalier RL.

Am J Physiol Renal Physiol. 2015 May 15;308(10):F1155-66. doi: 10.1152/ajprenal.00591.2014. Epub 2015 Feb 18.

31.

Diurnal suppression of EGFR signalling by glucocorticoids and implications for tumour progression and treatment.

Lauriola M, Enuka Y, Zeisel A, D'Uva G, Roth L, Sharon-Sevilla M, Lindzen M, Sharma K, Nevo N, Feldman M, Carvalho S, Cohen-Dvashi H, Kedmi M, Ben-Chetrit N, Chen A, Solmi R, Wiemann S, Schmitt F, Domany E, Yarden Y.

Nat Commun. 2014 Oct 3;5:5073. doi: 10.1038/ncomms6073.

32.

Ovarian dendritic cells act as a double-edged pro-ovulatory and anti-inflammatory sword.

Cohen-Fredarow A, Tadmor A, Raz T, Meterani N, Addadi Y, Nevo N, Solomonov I, Sagi I, Mor G, Neeman M, Dekel N.

Mol Endocrinol. 2014 Jul;28(7):1039-54. doi: 10.1210/me.2013-1400. Epub 2014 May 13.

33.

Time course of pathogenic and adaptation mechanisms in cystinotic mouse kidneys.

Gaide Chevronnay HP, Janssens V, Van Der Smissen P, N'Kuli F, Nevo N, Guiot Y, Levtchenko E, Marbaix E, Pierreux CE, Cherqui S, Antignac C, Courtoy PJ.

J Am Soc Nephrol. 2014 Jun;25(6):1256-69. doi: 10.1681/ASN.2013060598. Epub 2014 Feb 13.

34.

Dedifferentiation and aberrations of the endolysosomal compartment characterize the early stage of nephropathic cystinosis.

Raggi C, Luciani A, Nevo N, Antignac C, Terryn S, Devuyst O.

Hum Mol Genet. 2014 May 1;23(9):2266-78. doi: 10.1093/hmg/ddt617. Epub 2013 Dec 6.

35.

Chronic Akt1 deficiency attenuates adverse remodeling and enhances angiogenesis after myocardial infarction.

Vandoorne K, Vandsburger MH, Raz T, Shalev M, Weisinger K, Biton I, Brumfeld V, Raanan C, Nevo N, Eilam R, Hemmings BA, Tzahor E, Harmelin A, Gepstein L, Neeman M.

Circ Cardiovasc Imaging. 2013 Nov;6(6):992-1000. doi: 10.1161/CIRCIMAGING.113.000828. Epub 2013 Oct 17.

PMID:
24134954
36.

Goldenhar syndrome and medulloblastoma: a coincidental association? The first case report.

Aizenbud D, Shoham NV, Constantini S, Nevo N, Ben Arush M, Raz M, Rachmiel A, Goldsher D.

J Craniomaxillofac Surg. 2014 Jul;42(5):e91-6. doi: 10.1016/j.jcms.2013.07.003. Epub 2013 Aug 13.

PMID:
23953647
37.

Targeted therapy with low doses of 131I-MIBG is effective for disease palliation in highly refractory neuroblastoma.

Weyl Ben-Arush M, Ben Barak A, Bar-Deroma R, Ash S, Goldstein G, Golan H, Houri H, Waldman D, Nevo N, Bar Shalom R, Berniger A, Nevelsky A, Toren A, Yaniv I, Kuten A.

Isr Med Assoc J. 2013 Jan;15(1):31-4.

38.

Angiotensin 1-7 as means to prevent the metabolic syndrome: lessons from the fructose-fed rat model.

Marcus Y, Shefer G, Sasson K, Kohen F, Limor R, Pappo O, Nevo N, Biton I, Bach M, Berkutzki T, Fridkin M, Benayahu D, Shechter Y, Stern N.

Diabetes. 2013 Apr;62(4):1121-30. doi: 10.2337/db12-0792. Epub 2012 Dec 18.

39.

From ubiquitin-proteasomal degradation to CDK1 inactivation: requirements for the first polar body extrusion in mouse oocytes.

Pomerantz Y, Elbaz J, Ben-Eliezer I, Reizel Y, David Y, Galiani D, Nevo N, Navon A, Dekel N.

FASEB J. 2012 Nov;26(11):4495-505. doi: 10.1096/fj.12-209866. Epub 2012 Aug 2.

PMID:
22859367
40.

Fully refocused multi-shot spatiotemporally encoded MRI: robust imaging in the presence of metallic implants.

Ben-Eliezer N, Solomon E, Harel E, Nevo N, Frydman L.

MAGMA. 2012 Dec;25(6):433-42. doi: 10.1007/s10334-012-0318-7. Epub 2012 Jun 29.

PMID:
22743822
41.

Using the test of variables of attention to determine the effectiveness of modafinil in children with attention-deficit hyperactivity disorder (ADHD): a prospective methylphenidate-controlled trial.

Goez HR, Scott O, Nevo N, Bennett-Back O, Zelnik N.

J Child Neurol. 2012 Dec;27(12):1547-52. doi: 10.1177/0883073812439101. Epub 2012 Mar 23.

PMID:
22447850
42.

Cell lineage analysis of the mammalian female germline.

Reizel Y, Itzkovitz S, Adar R, Elbaz J, Jinich A, Chapal-Ilani N, Maruvka YE, Nevo N, Marx Z, Horovitz I, Wasserstrom A, Mayo A, Shur I, Benayahu D, Skorecki K, Segal E, Dekel N, Shapiro E.

PLoS Genet. 2012;8(2):e1002477. doi: 10.1371/journal.pgen.1002477. Epub 2012 Feb 23.

43.

Anti-thyroid cancer properties of a novel isoflavone derivative, 7-(O)-carboxymethyl daidzein conjugated to N-t-Boc-hexylenediamine in vitro and in vivo.

Somjen D, Grafi-Cohen M, Katzburg S, Weisinger G, Izkhakov E, Nevo N, Sharon O, Kraiem Z, Kohen F, Stern N.

J Steroid Biochem Mol Biol. 2011 Sep;126(3-5):95-103. doi: 10.1016/j.jsbmb.2011.04.009. Epub 2011 May 12.

PMID:
21600982
44.

Reactive oxygen species are indispensable in ovulation.

Shkolnik K, Tadmor A, Ben-Dor S, Nevo N, Galiani D, Dekel N.

Proc Natl Acad Sci U S A. 2011 Jan 25;108(4):1462-7. doi: 10.1073/pnas.1017213108. Epub 2011 Jan 10.

45.
46.

Epithelial cell transforming protein 2 (ECT2) depletion blocks polar body extrusion and generates mouse oocytes containing two metaphase II spindles.

Elbaz J, Reizel Y, Nevo N, Galiani D, Dekel N.

Endocrinology. 2010 Feb;151(2):755-65. doi: 10.1210/en.2009-0830. Epub 2009 Dec 8.

PMID:
19996184
47.

Central auditory processing development in adolescents with and without learning disabilities.

Moav R, Nevo N, Banai K.

J Basic Clin Physiol Pharmacol. 2009;20(3):207-17.

PMID:
19852308
48.

Renal phenotype of the cystinosis mouse model is dependent upon genetic background.

Nevo N, Chol M, Bailleux A, Kalatzis V, Morisset L, Devuyst O, Gubler MC, Antignac C.

Nephrol Dial Transplant. 2010 Apr;25(4):1059-66. doi: 10.1093/ndt/gfp553. Epub 2009 Oct 21.

PMID:
19846395
49.

Harnessing competing endocytic pathways for overcoming the tumor-blood barrier: magnetic resonance imaging and near-infrared imaging of bifunctional contrast media.

Migalovich HS, Kalchenko V, Nevo N, Meir G, Kohen F, Neeman M.

Cancer Res. 2009 Jul 1;69(13):5610-7. doi: 10.1158/0008-5472.CAN-08-4967. Epub 2009 Jun 9.

50.

Restrain of bone growth by estrogen-mimetic peptide-1 (EMP-1): a micro-computed tomographic study.

Kasher R, Bajayo A, Gabet Y, Nevo N, Fridkin M, Katchalski-Katzir E, Kohen F, Bab I.

Peptides. 2009 Jun;30(6):1181-6. doi: 10.1016/j.peptides.2009.02.019. Epub 2009 Mar 14.

PMID:
19463753

Supplemental Content

Support Center